BGMSP
Bio Green Med Solution, Inc.
Key Financials
Revenue
$0
↓ 100.0%
Net Income
$-2998000
↑ 73.3%
Operating Income
$-8427000
↑ 29.8%
Total Assets
$8.2M
↑ 99.9%
EPS (Diluted)
$-6.45
↓ 208.6%
Total Liabilities
$1.3M
↓ 78.6%
Cash & Equivalents
$3.5M
↑ 11.7%
Operating Cash Flow
$-4770000.00
↑ 40.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-4 | 6/16/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| 425 | 6/4/2026 | View on SEC |
| 8-K | 6/4/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| DEFR14A | 5/1/2026 | View on SEC |
| DEF 14A | 4/27/2026 | View on SEC |
| 8-K | 4/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BGMSP |
| Company Name | Bio Green Med Solution, Inc. |
| CIK | 1130166 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 908-517-7330 |